These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30744447)

  • 41. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy.
    Jackson N; Shukri A; Ali K
    Br J Haematol; 1993 Sep; 85(1):203-4. PubMed ID: 8251394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.
    Alizadeh H; Jaafar H; Kajtár B
    Ann Saudi Med; 2015; 35(6):468-71. PubMed ID: 26657232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of new generic formulations of imatinib mesylate on general quality of life in chronic phase chronic myeloid leukaemia patients.
    Uyanik MS; Pamuk GE; Maden M; Merev E; Cevik G; Uyanik V; Umit EG; Demir AM; Akker M
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26594025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Imatinib is effective in a 12-month-old boy with chronic myelogenous leukemia: case report and literature review].
    Pan Y; Wen S; Tian J; Lyu Z; Du Z; Yan L
    Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):194-7. PubMed ID: 26165016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.
    Mainor CB; Duffy AP; Atkins KL; Kimball AS; Baer MR
    J Oncol Pharm Pract; 2016 Apr; 22(2):374-7. PubMed ID: 25616656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: report of 3 cases and review of the literature.
    Mubarak AA; Kakil IR; Awidi A; Al-Homsi U; Fawzi Z; Kelta M; Al-Hassan A
    Am J Hematol; 2002 Feb; 69(2):115-8. PubMed ID: 11835347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
    Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
    Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment and Survival in Patients with Chronic Myeloid Leukemia in a Chronic Phase in West Iran.
    Payandeh M; Sadeghi M; Sadeghi E
    Asian Pac J Cancer Prev; 2015; 16(17):7555-9. PubMed ID: 26625761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.
    Koh LP; Kanagalingam D
    Int J Hematol; 2006 Dec; 84(5):459-62. PubMed ID: 17189230
    [No Abstract]   [Full Text] [Related]  

  • 50. [Tyrosine kinase inhibitors in the therapy of chronic myeloid leukaemia].
    Grzybowska-Izydorczyk O; Góra-Tybor J; Robak T
    Postepy Hig Med Dosw (Online); 2006; 60():490-7. PubMed ID: 17013368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imatinib--A New Tyrosine Kinase Inhibitor for First-Line Treatment of Chronic Myeloid Leukemia in 2015.
    Gambacorti-Passerini C; Piazza R
    JAMA Oncol; 2015 May; 1(2):143-4. PubMed ID: 26181011
    [No Abstract]   [Full Text] [Related]  

  • 52. Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting.
    Faye BF; Dieng N; Seck M; Gadji M; Gueye YB; Sy D; Toure SA; Sall A; Toure AO; Dieye TN; Diop S
    Ann Hematol; 2016 Oct; 95(10):1603-10. PubMed ID: 27370991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Responsiveness Of Childhood/Adolescent Chronic Myeloid Leukaemia Patients Of Pakistani Origin To Tyrosine Kinase Inhibitor.
    Muhammad Shah SY; ; Nawaz D; Lodhi AU; Rehman JU; Bahadar R; Ahmad Z; Banaras F
    J Ayub Med Coll Abbottabad; 2023; 35(2):313-315. PubMed ID: 37422828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted chronic myeloid leukemia therapy: Seeking a cure.
    Fausel C
    Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.
    Janeczko-Czarnecka M; Krawczuk-Rybak M; Karpińska-Derda I; Niedźwiecki M; Musioł K; Ćwiklińska M; Drabko K; Mycko K; Ociepa T; Pawelec K; Januszkiewicz-Lewandowska D; Ussowicz M; Rybka B; Ryczan-Krawczyk R; Kołtan A; Karolczyk G; Zaucha-Prażmo A; Badowska W; Kałwak K
    Adv Clin Exp Med; 2018 Jan; 27(1):91-98. PubMed ID: 29521048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.
    Carulli G; Baratè C; Marini A; Ottaviano V; Cervetti G; Fontanelli G; Guerrini F; Arici R; Guerri V; Di Paolo A; Polillo M; Ferreri MI; Galimberti S; Petrini M
    Hematol Oncol; 2015 Dec; 33(4):250-2. PubMed ID: 25256816
    [No Abstract]   [Full Text] [Related]  

  • 57. Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells.
    Marley SB; Lewis JL; Schneider H; Rudd CE; Gordon MY
    Br J Haematol; 2004 May; 125(4):500-11. PubMed ID: 15142121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country.
    Bee PC; Sekaran V; Ng RR; Kweh TY; Gan GG
    Singapore Med J; 2017 Mar; 58(3):150-154. PubMed ID: 27029807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre.
    Alizadeh H; Jaafar H; Rajnics P; Khan MI; Kajtár B
    Leuk Res; 2015 Jan; 39(1):47-51. PubMed ID: 25455655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resolution of Roth spots in chronic myeloid leukaemia after treatment with imatinib.
    Docherty SM; Reza M; Turner G; Bowles K
    Br J Haematol; 2015 Sep; 170(6):744. PubMed ID: 26119417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.